The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Tang, Jasmine Y M ^a   Singh, Rajendra Singh ^a   Cheung, Kwok L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; FULVESTRANT; PROGESTERONE RECEPTOR; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG DERIVATIVE; ESTRADIOL;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ESTROGEN DEFICIENCY; GASTROJEJUNOSTOMY; HUMAN; INTESTINE OBSTRUCTION; LUNG EMBOLISM; MALE; METASTASIS; PLEURA EFFUSION; RECURRENT DISEASE; SMALL INTESTINE OBSTRUCTION; STOMACH OBSTRUCTION; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUMOR BIOPSY; BREAST TUMOR; FEMALE; LUNG CARCINOMA; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, LOBULAR; ESTRADIOL; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 58149337068     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-128     Document Type: Article

References (12)

1. Robertson JF Fulvestrant (Faslodex) how to make a good drug better Oncologist 2007, 12(7):774-784 10.1634/theoncologist.12-7-774 17673609
2. Clavien P-A Laffer U Torhos J Harder F Gastrointestinal metastases as first clinical manifestation of the dissemination of a breast cancer Eur J Surg Oncol 1990, 16(2):121-126 2157608
3. Borst MJ Ingold JA Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast Surgery 1993, 114:637-642 8211676
4. Winston CB Hadar O Teitcher JB Caravelli JF Sklarin NT Panicek DM Liberman L Metastatic Lobular Carcinoma of the Breast: Patterns of Spread in the Chest, Abdomen, and Pelvis on CT AJR Am J Roentgenol 2000, 175(3):795-800 10954469
5. Sastre-Garaux X Jouve M Asselain B Vincent-Salomom A Beuzeboc P Infiltrating lobular carcinoma of the breast: Clinicopatholgic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns Cancer 1996, 77:113-120 10.1002/ (SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8 8630916
6. Piccart M Parker LM Pritchard KI Oestrogen receptor downregulation: An opportunity for extending the window of endocrine therapy in advanced breast cancer Annals of Oncology 2003, 14:1017-1025 10.1093/annonc/ mdg290 12853342
7. Babs GT Hans P Henk B Clinical Presentation, Endoscopic Features and Treatment of Gastric Metastases from Breast Carcinoma Cancer 2000, 89:2214-2221 10.1002/ 1097-0142(20001201)89:11<2214::AID-CNCR9>3.0.CO;2-D 11147591
8. Neven P Paridaens R Pelgrims G Martens M Bols A Goeminne JC Vindevoghel A Demol J Stragier B De Greve J Fontaine C Weyngaert Van Den D Becquart D Borms M Cocquyt V Broecke Van Den R Selleslags J Awada A Dirix L Van Dam P Azerad MA Vandenhoven G Christiaens MR Vergote I Fulvestrant (Faslodex mark) in advanced breast cancer: Clinical experience from a Belgian cooperative study Breast Cancer Res Treat 2008, 109:59-65 10.1007/s10549-007-9628-2 17592772
9. Mauriac L Pippen JE Albano JQ Gertlerd SZ Osborne CK Fulvestrant (Faslodex) versus anastrozole for the second-line treatment of subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials Eur J Cancer 2003, 39:1228-1233 10.1016/S0959-8049(03)00199-0 12763210
10. Howell A Robertson JFR Quaresma Albano J Aschermannova A Mauriac L Kleeberg UR Vergote I Erikstein B Webster A Morris C Fulvestrant (ICI 182,780) is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment Journal of Clinical Oncology 2002, 20:3396-3403 10.1200/JCO.2002.10.057 12177099
11. Osborne CK Pippen J Jones SE Parker LM Ellis M Come S Gertler SZ May JT Burton G Dimery I Webster A Morris C Elledge R Buzdar A A double-bline, randomized trial comparing the efficacy and tolerability of fulvestrant with anastrozole in post-menopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North Americal trial Journal of Clinical Oncology 2002, 20:3386-3395 10.1200/ JCO.2002.10.058 12177098
12. Howell A Robertson JFR Abram P Lichinitser MR Elledge R Bajetta E Watanabe T Morris C Webster A Dimery I Osborne CK Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated with Endocrine Therapy: A Multinational, Double-Bline, Randomized Trial Journal of Clinical Oncology 2004, 22:1605-1613 10.1200/JCO.2004.02.112 15117982